Clinical and therapeutic approach to childhood acne: An update

Pediatric Dermatology

Volumn 26, Issue 4, 2009, Pages 373-380

  Antoniou, C ^a   Dessinioti, Clio ^a   Stratigos, A J ^a   Katsambas, A D ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; ANTIANDROGEN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; AZELAIC ACID; BENZOYL PEROXIDE; CLINDAMYCIN; CORTICOSTEROID; ERYTHROMYCIN; HYDANTOIN; ISOTRETINOIN; KETOCONAZOLE; LITHIUM; OIL; ORAL CONTRACEPTIVE AGENT; PRASTERONE; PRASTERONE SULFATE; RETINOIC ACID; SPIRONOLACTONE; STEROID; TETRACYCLINE; TRIAMCINOLONE ACETONIDE;

ACNE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BONE INJURY; CAFFEY DISEASE; CALCIFICATION; CHILD; CHILDHOOD ACNE; CHILDHOOD DISEASE; CHILDHOOD GRANULOMATOUS PERIORIFICIAL DERMATITIS; CLINICAL EVALUATION; CLINICAL FEATURE; COMEDO; CONGENITAL ADRENAL HYPERPLASIA; CRYOTHERAPY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG ABSORPTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; ECZEMA; ERYTHEMA; EUROPE; FOOD AND DRUG ADMINISTRATION; FUNGUS CULTURE; HUMAN; HYPERANDROGENISM; IDIOPATHIC SKELETAL HYPEROSTOSIS; INFANTILE ACNE; INFLAMMATORY DISEASE; LACTATE DEHYDROGENASE BLOOD LEVEL; LONG TERM CARE; LOW DRUG DOSE; MALASSEZIA; MEDICAL DECISION MAKING; MELANOSIS; MOOD CHANGE; NEONATAL CEPHALIC PUSTULOSIS; NEWBORN ACNE; OINTMENT; OSTEOPOROSIS; OVARY POLYCYSTIC DISEASE; PERIOSTEAL THICKENING; PREMATURE EPIPHYSEAL CLOSURE; PREPUBERTAL ACNE; PREPUBERTY; PRIORITY JOURNAL; PROGNOSIS; PUSTULAR MILIARIA; PUSTULOSIS; REVIEW; SCAR FORMATION; SEBACEOUS GLAND; SEBORRHEA; SIDE EFFECT; SKIN DISEASE; SKIN INFLAMMATION; SWEAT GLAND DISEASE; TOOTH INJURY; TOXIC ERYTHEMA; TRANSIENT NEONATAL PUSTULAR MELANOSIS; TREATMENT DURATION; TREATMENT FAILURE; UMBILICAL GRANULATION TISSUE; XERODERMA PIGMENTOSUM;

ACNE VULGARIS; ADMINISTRATION, ORAL; AGE OF ONSET; CICATRIX; DERMATOLOGIC AGENTS; HUMANS; ISOTRETINOIN; PEDIATRICS; SEVERITY OF ILLNESS INDEX; TETRACYCLINES;

EID: 68849096455     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2009.00932.x     Document Type: Review

References (52)

1. Jansen T, Burgdorf WHC, Plewig G. Pathogenesis and treatment of acne in childhood. Pediatr Dermatol 1997 14 : 17 21.
2. Herane MI, Ando I. Acne in infancy and acne genetics. Dermatology 2003 206 : 24 28.
3. Agache P, Blanc D, Barrand C et al. Sebum levels during the first year of life. Br J Dermatol 1980 103 : 643 649.
4. Henderson CA, Taylor J, Cunliffe WJ. Sebum excretion rates in mothers and neonates. Br J Dermatol 2000 142 : 110 111.
5. Paller AS, Mancini AJ (eds.) Disorders of the sebaceous and sweat glands. In : Hurwitz Clinical Pediatric Dermatology, 3rd ed. Philadelphia : WB Saunders, 2006 : 195 196.
6. Lucky AW. A review of infantile and pediatric acne. Dermatology 1998 196 : 95 97.
7. Borderon JC, Langier J, Vaillant MC. Colonisation du nouveau-né par Malassezia furfur. Bull Soc Fr Mycol Med 1989 1 : 129 132.
8. Ayhan M, Sancak B, Karaduman A et al. Colonization of neonate skin by Malassezia species relationship with neonatal cephalic pustulosis. J Am Acad Dermatol 2007 57 : 1012 1018.
9. Aractingi S, Cadranel S, Reygagne P et al. Pustulose neonatale induite par Malassezia furfur. Ann Dermatol Venereol 1991 118 : 856 858.
10. Niamba P, Weill FX, Sarlangue J et al. Is common neonatal cephalic pustulosis (neonatal acne) triggered by Malassezia sympodialis? Arch Dermatol 1998 134 : 995 998.
11. Rapelanoro R, Mortureux P, Coupie B et al. Neonatal Malassezia furfur pustulosis. Arch Dermatol 1996 132 : 190 193.
12. Koseki S, Takahashi S. Serial observation of the colonization of Pityrosporum orbiculare (ovale) on the facial skin surface of newborn infants. Jpn J Med Mycol 1988 29 : 209 215.
13. Bardazzi F. Transient cephalic neonatal pustulosis. Arch Dermatol 1997 133 : 528 529.
14. Bernier V, Weill FX, Hirigoyen V et al. Skin colonization by μalassezia species in neonates: a prospective study and relationship with neonatal cephalic pustulosis. Arch Dermatol 2002 138 : 215 218.
15. Bergman JN, Eichenfield LF. Neonatal acne and cephalic pustulosis: is malassezia the whole story? Arch Dermatol 2002 138 : 255 256.
16. Katsambas AD, Katoulis AC, Stavropoulos P. Acne neonatorum: a study of 22 cases. Int J Dermatol 1999 38 : 128 130.
17. Nanda S, Reddy BSN, Ramji S et al. Analytical study of pustular eruptions in neonates. Pediatr Dermatol 2002 19 : 210 215.
18. Yonkosky DM, Pochi PE. Acne vulgaris in childhood: pathogenesis and management. Dermatol Clin 1986 4 : 127 136.
19. Cantatore-Francis JL, Glick SA. Childhood acne: evaluation and management. Dermatol Ther 2006 19 : 202 209.
20. Liu C, Feng J, Qu R et al. Epidemiologic study of the predisposing factors in erythema toxicum neonatorum. Dermatology 2005 210 : 269 272.
21. Van Praag MCG, Van Rooij RWG, Folkers E et al. Diagnosis and treatment of pustular disorders in the neonate. Pediatr Dermatol 1997 14 : 131 143.
22. Gupta AK, Ramussen JE. What's new in pediatric dermatology. J Am Acad Dermatol 1988 18 : 239 259.
23. Ray WA, Federspiel CF, Schaffner W. Prescribing of tetracycline to children less than 8 years old. JAMA 1977 237 : 2069 2074.
24. Kang SK, Jee MS, Choi JH et al. A case of infantile acne due to Pityrosporum. Pediatr Dermatol 2003 20 : 68 70.
25. Duke EMC. Infantile acne associated with transient increases in plasma concentrations of luteinising hormone, follicle stimulating hormone, and testosterone. Br Med J 1981 282 : 1275 1276.
26. Mann MW, Ellis SS, Mallory SB. Infantile acne as the initial sign of an adrenocortical tumor. J Am Acad Dermatol 2007 56 (2 Suppl S15 S18.
27. Barnes CJ, Eichenfield LF, Lee J et al. A practical approach for the use of oral isotretinoin for infantile acne. Pediatr Dermatol 2005 22 : 166 169.
28. Cunliffe WJ, Baron SE, Coulson IH. A clinical and therapeutic study of 29 patients with infantile acne. Br J Dermatol 2001 145 : 463 466.
29. Chew EW, Bingham A, Burrows D. Incidence of acne vulgaris in patients with infantile acne. Clin Exp Dermatol 1990 13 : 376 377.
30. Kose O, Koc E, Arca E. Adapalene gel 0.1% in the treatment of infantile acne: an open clinical study. Pediatr Dermatol 2008 25 : 383 386.
31. Brecher AR, Orlow SJ. Oral retinoid therapy for dermatologic conditions in children and adolescents. J Am Acad Dermatol 2003 49 : 171 182.
32. The European Agency for the Evaluation of Medicinal Products. Committee for Proprietary Medicinal Products. Summary Information on a Referral Opinion Following an Arbitration Pursuant to Article 29 of Directive 2001/83/Ec for Isotretinoin, CPMP/8211/03, October 17. The European Agency for the Evaluation of Medicinal Products, 2003. Available at: http://www.emea.europa.eu/pdfs/human/ referral/roaccutane/284603en.pdf.
33. Arbegast KD, Braddock SW, Lamberty LF et al. Treatment of infantile cystic acne with oral isotretinoin: a case report. Pediatr Dermatol 1991 8 : 166 168.
34. Horne HL, Carmichael AJ. Juvenile nodulocystic acne responding to systemic isotretinoin. Br J Dermatol 1997 136 : 796 797.
35. Mengesha YM, Hansen RC. Toddler-age nodulocystic acne. J Pediatr 1999 134 : 644 648.
36. Burket JM, Storrs FJ. Nodulocystic infantile acne occurring in a kindred of steatocystoma. Arch Dermatol 1987 123 : 432 433.
37. Sarazin F, Dompmartin A, Nivot S et al. Treatment of an infantile acne with oral isotretinoin. Eur J Dermatol 2004 14 : 71 72.
38. Torrelo A, Pastor A, Zambrano A. Severe acne infantum successfully treated with isotretinoin. Pediatr Dermatol 2005 22 : 357 359.
39. Leaute-Labreze C, Gautier C, Labbe L et al. Acné infantile et isotrétinoine. Ann Dermatol Venereol 1998 125 : 132 134.
40. DiGiovanna JJ. Isotretinoin effects on bone. J Am Acad Dermatol 2001 45 (Suppl S176 S182.
41. Kraemer KH, DiGiovann JJ, Moshell AN et al. Prevention of skin cancer in xeroderma pigmentosa with the use of oral isotretinoin. N Engl J Med 1988 318 : 1633 1637.
42. Prendiville J, Bingham EA, Burrows D. Premature epiphyseal closure-a complication of etretinate therapy in children. J Am Acad Dermatol 1986 15 : 1259 1262.
43. Milstone LM, McGuire J, Ablow RC. Premature epiphyseal closure in a child receiving oral 13-cis-retinoic acid. J Am Acad Dermatol 1982 7 : 663 666.
44. Tran A, Walker J, Shulakewych M. Premature epiphyseal closure in pediactric patients on isotretinoin therapy. J Am Acad Dermatol 2008 58 (suppl 2 AB7 [Poster Abstract].
45. Katugampola RP, Finlay AY. Oral retinoid therapy for disorders of keratinisation: single-centre retrospective 25 years' experience on 23 patients. Br J Dermatol 2006 154 : 267 276.
46. Stewart ME, Downing DT, Cook JS et al. Sebaceous gland activity and serum dehydroepiandrosterone sulfate levels in boys and girls. Arch Dermatol 1992 128 : 1345 1348.
47. Lucky AW, Biro FM, Huster GA et al. Acne vulgaris in premenanrchal girls. An early sign of puberty assoicated with rising levels of dehydroepiandrosterone. Arch Dermatol 1994 130 : 308 314.
48. Lucky AW, Biro FM, Simbartl LA et al. Predictors of severity of acne vulgaris in young adolescent girls: results of a five year longitudinal study. J Pediatr 1997 130 : 30 39.
49. Rademaker M, Garioch JJ, Simpson MB. Acne in school-children: no longer a concern for dermatologists. BMJ 1989 298 : 1217 1219.
50. Lucky AW, Biro FM, Huster GA et al. Acne vulgaris in early adolescent boys: correlations with pubertal maturation and age. Arch Dermatol 1991 127 : 210 216.
51. Strauss JS, Krowchuk DP, Leyden JJ et al. Guidelines of care for acne vulgaris management. J Am Acad Dermatol 2007 56 : 651 663.
52. Urbatsch AJ, Frieden I, Williams ML. Extrafacial and generalized granulomatous periorificial dermatitis. Arch Dermatol 2002 138 : 1354 1358.